These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 21234526)
21. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck. Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112 [TBL] [Abstract][Full Text] [Related]
22. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma]. Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443 [TBL] [Abstract][Full Text] [Related]
23. [Induction chemotherapy and larynx preservation: is such practice useful?]. Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041 [TBL] [Abstract][Full Text] [Related]
24. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy. Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311 [TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin. Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341 [TBL] [Abstract][Full Text] [Related]
26. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma]. Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552 [TBL] [Abstract][Full Text] [Related]
27. Phase I/II study of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. Herchenhorn D; Dias FL; Viegas CM; Federico MH; Araújo CM; Small I; Bezerra M; Fontão K; Knust RE; Ferreira CG; Martins RG Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):696-702. PubMed ID: 20421154 [TBL] [Abstract][Full Text] [Related]
29. [Current role for induction chemotherapy in head and neck tumors]. Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986 [TBL] [Abstract][Full Text] [Related]
30. Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study. Semrau R; Temming S; Preuss SF; Klubmann JP; Guntinas-Lichius O; Müller RP Strahlenther Onkol; 2011 Oct; 187(10):645-50. PubMed ID: 21947123 [TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
32. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx. Rivera F; Vega-Villegas ME; López-Brea MF; García-Castaño A; de Juan A; Collado A; Galdós P; Rubio A; del Valle A; Rama J; Sanz-Ortiz J Laryngoscope; 2004 Jul; 114(7):1163-9. PubMed ID: 15235341 [TBL] [Abstract][Full Text] [Related]
33. [Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study]. Rubio Suárez A; Teigeiro Núñez V; Gallo Terán J; Señaris González B; Mesuro Domínguez N Acta Otorrinolaringol Esp; 2003 Dec; 54(10):697-703. PubMed ID: 15164709 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma]. Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223 [TBL] [Abstract][Full Text] [Related]
35. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399. Cmelak AJ; Li S; Goldwasser MA; Murphy B; Cannon M; Pinto H; Rosenthal DI; Gillison M; Forastiere AA J Clin Oncol; 2007 Sep; 25(25):3971-7. PubMed ID: 17761982 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Furusaka T; Asakawa T; Tanaka A; Matsuda H; Ikeda M Acta Otolaryngol; 2012 Oct; 132(10):1108-14. PubMed ID: 22998559 [TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma. Kong L; Zhang YW; Hu CS; Guo Y Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907 [TBL] [Abstract][Full Text] [Related]
38. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up. Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190 [TBL] [Abstract][Full Text] [Related]
39. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II. Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221 [TBL] [Abstract][Full Text] [Related]
40. Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis. Birnbaum A; Dipetrillo T; Rathore R; Anderson E; Wanebo H; Puthwala Y; Joyce D; Safran H; Henderson D; Kennedy T; Ready N; Sio TT Am J Clin Oncol; 2010 Apr; 33(2):144-7. PubMed ID: 19786848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]